Inclusion Criteria:
- Patients greater or equal to 18 years of age.
- Bitten by a cat.
- Location of bite is the hand and/or forearm (distal to elbow).
- Presenting <24 hours following a cat bite to the hand/forearm.
- English speaking
Exclusion Criteria:
- Patients who present with active local or systemic infections
1. Purulent drainage from the cat bite
2. Redness AND swelling at the location of the cat bite
- Having a fever >100.4° F or >38° C)-Received antibiotics within the past 30 days
- Received antibiotics within the past 30 days
- Patients unwilling to take study medication
- Patients unwilling to attend scheduled follow-up evaluations or complete study forms
- Pregnant Women
- Type I hypersensitivity reaction to any of the study interventions
- Immunocompromised patients (primary and secondary immunodeficiencies) Primary
- Autoimmune Lymphoproliferative Syndrome (ALPS)
- Autoimmune Polyglandular Syndrome type 1 (APS-1)
- B-cell Expansion with Nuclear factor kappa-light-chain-enhancer of activated B cells and T-cell Anergy (BENTA) Disease
- Caspase Eight Deficiency State (CEDS)
- Caspase Recruitment Domain Family Member 9 (CARD9) Deficiency and Other Syndromes of Susceptibility to Candidiasis
- Cartilage-hair hypoplasia
- Chédiak-Higashi syndrome
- Chronic Granulomatous Disease (CGD)
- Common Variable Immunodeficiency (CVID)
- Complement Deficiencies
- Congenital Neutropenia Syndromes
- Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4) Deficiency
- Cyclic neutropenia
- DiGeorge syndrome
- Dedicator Of Cytokinesis 8 (DOCK8) Deficiency
- GATA-binding protein 2 (GATA2) Deficiency
- Glycosylation Disorders with Immunodeficiency
- Hyper-Immunoglobulin E Syndromes (HIES)
- Hyper-Immunoglobulin M Syndromes
- Interferon Gamma, Interleukin 12 and Interleukin 23 Deficiencies
- Leukocyte Adhesion Deficiency (LAD) Types 1 and 2
- Lipopolysaccharide Responsive Beige-Like Anchor Protein (LRBA) Deficiency
- Phosphatidylinositol 3-kinase (PI3-Kinase) Disease
- Phospholipase C gamma 2 (PLCG2) associated Antibody Deficiency and Immune Dysregulation (PLAID)
- Severe Combined Immunodeficiency (SCID)
- Selective Immunoglobulin A (IgA) deficiency
- Signal transducer and activator of transcription 3 (STAT3) Dominant-Negative Disease
- STAT3 Gain-of-Function Disease
- Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
- Wiskott-Aldrich Syndrome (WAS)
- X-Linked Agammaglobulinemia (XLA)
- X-Linked Lymphoproliferative Disease (XLP)
- X-linked magnesium transporter 1 (MAGT1) deficiency with increased susceptibility to Epstein-Barr virus (EBV) infection and N-linked glycosylation defect (XMEN) Disease
- Zeta-associated protein 70 (ZAP-70) deficiency
Secondary
- Malnutrition
- Uncontrolled Diabetes mellitus
- Chronic uremia
- Genetic syndromes: trisomy 21
- Immunomodulatory, immunosuppressive drug therapy: corticosteroids, calcineurin inhibitors, cytotoxic agents
- Systemic lupus erythematosus
- Malignancy
- Active radiation therapy
- Bone marrow ablation
- Infectious diseases: human immunodeficiency virus (HIV) infection, Hepatitis
Additional Primary and secondary immunodeficiencies can be found at the following link.
https://www.merckmanuals.com/professional/immunology-allergic-disorders/immunodeficiency-disorders/overview-of-immunodeficiency-disorders